The effect of long term complementary nutritional support via percutaneous jejunostomy after pancreaticoduodenectomy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00010237

Enrollment

180

Registered

2016-08-25

Start date

2016-10-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C25.0 R64

Interventions

Group 1: Pancreaticoduodenectomy with a percutaneous jejunostomy. 7 days parenteral nutrition with 50% of the ideal body weight. Energy deficit covering complementary enteral nutrition via percutaneou

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Pancreaticoduodenectomy for pancreatic carcinoma, = 18 years

Exclusion criteria

Exclusion criteria: Metastasized pancreatic carcinoma other than lymph node metastases, parenteral nutrition, secondary tumor, active chronic gastrointestinal disease, stop of the complementary nutrition for more than 3 days, cardial or renal diseases as a contraindication for the enteral complementary nutrition.

Design outcomes

Primary

Measure	Time frame
Morbidity 12 weeks postoperatively, graded according to the Clavien-Dindo classification	—

Secondary

Measure	Time frame
- Quality of Life (QLQ-PAN26, QLQ-PAN30) - Total Energy Intake - Nutritional status und Bodycomposition (Muscle-, Fatmass, etc.) -Survival -Delay, abortion of adjuvanten treatments	—

Countries

Switzerland

Contacts

Public ContactKaspar Zgraggen

Berner ViszeralchirurgieKlinik Beau Site Bern

kaspar.zgraggen@hirslanden.ch+41 31 335 3939

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 28, 2026